GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

1
Player Avatar jackbot (38.14) Submitted: 11/16/2009 9:38:01 AM : Underperform Start Price: $3.60 GTXI Score: +10.51

It may not be fair, but the FDA wants data that GTX doesn't have. They don't have cash to do more trials. Sad story.

Featured Broker Partners


Advertisement